• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无尿在腹膜透析患者硫酸吲哚酚与贫血关系中的作用。

Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients.

作者信息

Huang Jeng-Yi, Hsu Ching-Wei, Yang Chih-Wei, Hung Cheng-Chieh, Huang Wen-Hung

机构信息

Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Linkou Branch, Taipei; Chang Gung University School of Medicine, Taoyuan, Taiwan.

出版信息

Ther Clin Risk Manag. 2016 Nov 28;12:1797-1803. doi: 10.2147/TCRM.S120012. eCollection 2016.

DOI:10.2147/TCRM.S120012
PMID:27932887
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5135005/
Abstract

BACKGROUND

Experimental evidence suggests that indoxyl sulfate (IS) is associated with chronic kidney disease-related anemia. However, clinical studies are limited, and few have explored the potential confounding effect of anuria. This study, thus, evaluated the association between IS and anemia in both non-anuric and anuric peritoneal dialysis (PD) patients.

METHODS

This cross-sectional and observational study included 165 chronic PD patients aged 19-84 years. Their serum IS levels in total and free forms were measured by ultra performance liquid chromatography. Correlations between serum IS and hemoglobin (Hb) were performed in both non-anuric and anuric groups.

RESULTS

Among the study subjects, 90 were non-anuric and 75 were anuric. As a whole, there was no correlation between IS and Hb. Nonetheless, subsequent analysis of the non-anuric patients showed that Hb is negatively correlated with IS levels ( =-0.405, <0.001 for total form and =-0.296, =0.005 for free form). Factors that significantly affected Hb levels in the stepwise multiple regression analysis include total IS and iron saturation. In contrast for anuric patients, serum ferritin, albumin, iron saturation, use of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker, but not serum IS, were predictors for anemia in the multiple regression model.

CONCLUSIONS

Serum IS is associated with an increased severity of anemia in non-anuric PD patients and not in anuric ones, indicating anuria could be a confounding factor in such association.

摘要

背景

实验证据表明,硫酸吲哚酚(IS)与慢性肾脏病相关贫血有关。然而,临床研究有限,且很少有研究探讨无尿的潜在混杂效应。因此,本研究评估了非无尿和无尿腹膜透析(PD)患者中IS与贫血之间的关联。

方法

这项横断面观察性研究纳入了165例年龄在19至84岁之间的慢性PD患者。通过超高效液相色谱法测量其血清中总形式和游离形式的IS水平。在非无尿组和无尿组中分别进行血清IS与血红蛋白(Hb)之间的相关性分析。

结果

在研究对象中,90例为非无尿患者,75例为无尿患者。总体而言,IS与Hb之间无相关性。尽管如此,对非无尿患者的后续分析表明,Hb与IS水平呈负相关(总形式:r = -0.405,P < 0.001;游离形式:r = -0.296,P = 0.005)。逐步多元回归分析中显著影响Hb水平的因素包括总IS和铁饱和度。相比之下,对于无尿患者,血清铁蛋白、白蛋白、铁饱和度、使用血管紧张素转换酶抑制剂/血管紧张素II受体阻滞剂是多元回归模型中贫血的预测因素,而血清IS不是。

结论

血清IS与非无尿PD患者贫血严重程度增加相关,而与无尿患者无关,表明无尿可能是这种关联中的一个混杂因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7470/5135005/a19890ed6f42/tcrm-12-1797Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7470/5135005/a19890ed6f42/tcrm-12-1797Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7470/5135005/a19890ed6f42/tcrm-12-1797Fig1.jpg

相似文献

1
Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients.无尿在腹膜透析患者硫酸吲哚酚与贫血关系中的作用。
Ther Clin Risk Manag. 2016 Nov 28;12:1797-1803. doi: 10.2147/TCRM.S120012. eCollection 2016.
2
Serum Concentration of Indoxyl Sulfate in Peritoneal Dialysis Patients and Low-Flux Hemodialysis Patients.血清吲哚硫酸酯浓度在腹膜透析患者和低通量血液透析患者中的研究。
Blood Purif. 2019;48(2):183-190. doi: 10.1159/000499749. Epub 2019 Apr 30.
3
Survival predictors in anuric patients on peritoneal dialysis: A prospective, multicenter, propensity score-matched cohort study.腹膜透析无尿患者的生存预测因素:一项前瞻性、多中心、倾向评分匹配队列研究。
PLoS One. 2018 Apr 25;13(4):e0196294. doi: 10.1371/journal.pone.0196294. eCollection 2018.
4
High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients.腹膜透析患者中肾蛋白结合尿毒症毒素(硫酸吲哚酚和对甲酚硫酸盐)清除率与肾水溶性毒素之间存在高度相关性。
Ther Apher Dial. 2012 Aug;16(4):361-7. doi: 10.1111/j.1744-9987.2012.01068.x. Epub 2012 Apr 11.
5
Factors associated with blood concentrations of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis.与腹膜透析患者血中硫酸吲哚酚和对甲酚浓度相关的因素。
Perit Dial Int. 2010 Jul-Aug;30(4):456-63. doi: 10.3747/pdi.2009.00092. Epub 2010 Mar 25.
6
Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients.吲哚-3-乙酸、硫酸吲哚酚和对甲酚硫酸酯不影响血液透析患者的贫血参数。
BMC Nephrol. 2017 Jul 26;18(1):251. doi: 10.1186/s12882-017-0668-5.
7
Predictors of survival in anuric peritoneal dialysis patients.无尿腹膜透析患者的生存预测因素。
Kidney Int. 2005 Sep;68(3):1199-205. doi: 10.1111/j.1523-1755.2005.00512.x.
8
The relationship between Kt/V(urea) and nPNA in anuric peritoneal dialysis patients: a comparison with predialysis patients.无尿腹膜透析患者的尿素清除指数(Kt/V)与标准化蛋白氮出现率(nPNA)之间的关系:与透析前患者的比较
Perit Dial Int. 2001 Sep-Oct;21(5):509-15.
9
Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function.对不同程度残余肾功能的腹膜透析患者预后预测因素的重要区分。
Nephrol Dial Transplant. 2005 Feb;20(2):396-403. doi: 10.1093/ndt/gfh331. Epub 2004 Jun 8.
10
Potassium metabolism in continuous ambulatory peritoneal dialysis patients.持续性非卧床腹膜透析患者的钾代谢
Ren Fail. 2014 Jun;36(5):748-54. doi: 10.3109/0886022X.2014.884379. Epub 2014 Feb 11.

引用本文的文献

1
Gut Dysbiosis and Its Role in the Anemia of Chronic Kidney Disease.肠道菌群失调及其在慢性肾脏病贫血中的作用。
Toxins (Basel). 2024 Nov 17;16(11):495. doi: 10.3390/toxins16110495.
2
Is there an association between the plasma levels of uremic toxins from gut microbiota and anemia in patients on hemodialysis?血液透析患者肠道微生物群产生的尿毒症毒素血浆水平与贫血之间是否存在关联?
Int Urol Nephrol. 2022 Jun;54(6):1271-1277. doi: 10.1007/s11255-021-03001-7. Epub 2021 Sep 24.
3
Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis.

本文引用的文献

1
Serum Concentrations of p-Cresyl Sulfate and Indoxyl Sulfate, but Not Inflammatory Markers, Increase in Incident Peritoneal Dialysis Patients in Parallel with Loss of Residual Renal Function.对甲酚硫酸酯和吲哚硫酸酯的血清浓度,而非炎症标志物,在新发腹膜透析患者中与残余肾功能丧失同步升高。
Perit Dial Int. 2015 Jul-Aug;35(4):492. doi: 10.3747/pdi.2015.00095.
2
Oral adsorbent AST-120 potentiates the effect of erythropoietin-stimulating agents on Stage 5 chronic kidney disease patients: a randomized crossover study.口服吸附剂 AST-120 增强促红细胞生成素刺激剂对 5 期慢性肾脏病患者的疗效:一项随机交叉研究。
Nephrol Dial Transplant. 2014 Sep;29(9):1719-27. doi: 10.1093/ndt/gfu061. Epub 2014 Apr 8.
3
慢性肾脏病中降低蛋白结合型尿毒症毒素的策略:系统评价和荟萃分析。
J Nephrol. 2021 Dec;34(6):1805-1817. doi: 10.1007/s40620-020-00955-2. Epub 2021 Jan 23.
4
The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease.降压药物治疗对慢性肾脏病患者蛋白结合尿毒症毒素(硫酸吲哚酚)与炎症标志物相互作用的影响。
Int Urol Nephrol. 2019 Mar;51(3):491-502. doi: 10.1007/s11255-018-02064-3. Epub 2019 Jan 7.
5
Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients.吲哚-3-乙酸、硫酸吲哚酚和对甲酚硫酸酯不影响血液透析患者的贫血参数。
BMC Nephrol. 2017 Jul 26;18(1):251. doi: 10.1186/s12882-017-0668-5.
Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate.
尿毒素吲哚硫酸酯诱导自杀性红细胞死亡。
BMC Nephrol. 2013 Nov 4;14:244. doi: 10.1186/1471-2369-14-244.
4
Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner.硫酸吲哚酚,一种有代表性的尿毒症毒素,以依赖 HIF 的方式抑制促红细胞生成素的产生。
Lab Invest. 2011 Nov;91(11):1564-71. doi: 10.1038/labinvest.2011.114. Epub 2011 Aug 22.
5
Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins.估算肾小球滤过率是一种对广泛范围的尿毒症毒素的浓度预测能力较差的方法。
Clin J Am Soc Nephrol. 2011 Jun;6(6):1266-73. doi: 10.2215/CJN.09981110. Epub 2011 May 26.
6
Cardiorenal protective effect of the oral uremic toxin absorbent AST-120 in chronic heart disease patients with moderate CKD.口服尿毒症毒素吸附剂 AST-120 在伴有中度 CKD 的慢性心脏病患者中的心肾保护作用。
J Nephrol. 2010 Sep-Oct;23(5):535-40.
7
Factors associated with blood concentrations of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis.与腹膜透析患者血中硫酸吲哚酚和对甲酚浓度相关的因素。
Perit Dial Int. 2010 Jul-Aug;30(4):456-63. doi: 10.3747/pdi.2009.00092. Epub 2010 Mar 25.
8
Vitamin D deficiency and anemia in early chronic kidney disease.维生素 D 缺乏和慢性肾脏病早期贫血。
Kidney Int. 2010 Apr;77(8):715-20. doi: 10.1038/ki.2009.551. Epub 2010 Feb 3.
9
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.阿法达贝泊汀治疗2型糖尿病和慢性肾病的一项试验。
N Engl J Med. 2009 Nov 19;361(21):2019-32. doi: 10.1056/NEJMoa0907845. Epub 2009 Oct 30.
10
Serum indoxyl sulfate levels in patients with diabetic nephropathy: relation to renal function.糖尿病肾病患者的血清硫酸吲哚酚水平:与肾功能的关系
Diabetes Res Clin Pract. 2009 Feb;83(2):220-6. doi: 10.1016/j.diabres.2008.09.053. Epub 2008 Nov 22.